Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03577028
What this trial is testing

Study of HPN424 in Patients With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Cancer
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 104
Not applicableStudy completedNCT03329742
What this trial is testing

Sipuleucel-T and Low-protein Diet in Patients With Metastatic Castrate-resistant Prostate Cancer

Who this might be right for
Prostate Cancer Recurrent
Indiana University 2
Testing effectiveness (Phase 2)Looking for participantsNCT05534646
What this trial is testing

Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate Cancer
Edwin Posadas, MD 100
Not applicableUnknownNCT04839653
What this trial is testing

Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria

Who this might be right for
Pneumonia, Ventilator-AssociatedPneumoniaBloodstream Infection+4 more
MEDSI Clinical Hospital 1, ICU 60
Very early researchUnknownNCT04225910
What this trial is testing

Clinical Trial of Ac225-PSMA Radioligand Therapy of Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 20
Early research (Phase 1)Study completedNCT02655822
What this trial is testing

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

Who this might be right for
Renal Cell CancerMetastatic Castration Resistant Prostate Cancer
Corvus Pharmaceuticals, Inc. 502
Early research (Phase 1)Study completedNCT01347788
What this trial is testing

Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Massachusetts General Hospital 34
Not applicableStudy completedNCT03658486
What this trial is testing

Exercise for Advanced Prostate Cancer: a Multicomponent Feasibility Trial

Who this might be right for
Prostate Cancer MetastaticCastration-resistant Prostate Cancer
Queen's University, Belfast 30
Testing effectiveness (Phase 2)Study completedNCT00028873
What this trial is testing

R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 35
Testing effectiveness (Phase 2)Looking for participantsNCT06100705
What this trial is testing

Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Yale University 26
Testing effectiveness (Phase 2)Looking for participantsNCT06267729
What this trial is testing

Study of AZD0754 in Participants With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
AstraZeneca 60
Testing effectiveness (Phase 2)Study completedNCT05655715
What this trial is testing

Checkpoint Inhibitors and SBRT for MCRPC

Who this might be right for
Prostate Cancer MetastaticCastrate Resistant Prostate CancerMetastatic Castration-resistant Prostate Cancer+1 more
Herlev and Gentofte Hospital 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623460
What this trial is testing

Zanzalintinib Efficacy Post Pluvicto® in Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer

Who this might be right for
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Stuthi Perimbeti 30
Testing effectiveness (Phase 2)WithdrawnNCT02965417
What this trial is testing

Sym004 in Metastatic Colorectal Cancer and ECD-EGFR Patients

Who this might be right for
Metastatic Colorectal Cancer
Symphogen A/S
Testing effectiveness (Phase 2)Looking for participantsNCT06288113
What this trial is testing

Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial

Who this might be right for
Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
Jonsson Comprehensive Cancer Center 40
Early research (Phase 1)UnknownNCT04839991
What this trial is testing

Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours.

Who this might be right for
Advanced and/or Metastatic Solid Tumours
Crescendo Biologics Ltd. 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06544460
What this trial is testing

Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients

Who this might be right for
Ovarian Cancer
Fudan University 94
Not applicableStudy completedNCT01385280
What this trial is testing

Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerProgesterone Receptor Positive TumorRecurrent Breast Cancer+2 more
University of Arizona 13
Early research (Phase 1)Not Yet RecruitingNCT07423117
What this trial is testing

ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy

Who this might be right for
Metastatic Castration-resistant Prostate CancerNon-small Cell Lung CancerTriple Negative Breast Cancer+1 more
IntoCell, Inc 102
Testing effectiveness (Phase 2)Ended earlyNCT04957290
What this trial is testing

NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors

Who this might be right for
Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors
Noxopharm Limited 21
Next Page